We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MRKR market cap is 13.39M. The company's latest EPS is USD -1.0021 and P/E is -1.25.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.06M | 1.24M | 1.17M | 1.93M | 2.25M |
| Operating Income | -2.94M | -2.55M | -2.31M | -2.4M | -3.86M |
| Net Income | -2.8M | -2.39M | -2.19M | -2.31M | -3.84M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 467k | 1.24M | 9.01M | 3.31M | 6.59M |
| Operating Income | -28.89M | -39.48M | -29.95M | -14.58M | -11.12M |
| Net Income | -28.71M | -41.88M | -29.93M | -8.24M | -10.73M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.13M | 14.09M | 11.68M | 10.91M | 22.02M |
| Total Liabilities | 3.07M | 2.3M | 1.97M | 3.46M | 3.47M |
| Total Equity | 14.05M | 11.79M | 9.7M | 7.45M | 18.56M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.62M | 68.14M | 34.42M | 17.13M | 22.02M |
| Total Liabilities | 18.27M | 24.15M | 14.82M | 3.07M | 3.47M |
| Total Equity | 27.35M | 43.99M | 19.6M | 14.05M | 18.56M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.44M | -3.84M | -7.4M | -6.21M | -10.91M |
| Investing | 18.66M | N/A | N/A | N/A | N/A |
| Financing | 1.11M | 49k | 93k | 96k | 14.99M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.86M | -27.28M | -26.97M | -16.44M | -10.91M |
| Investing | -10.43M | -3.13M | -4.95M | 18.66M | N/A |
| Financing | 6.74M | 52.56M | 202k | 1.11M | 14.99M |
| Market Cap | 13.39M |
| Price to Earnings Ratio | -1.25 |
| Price to Sales Ratio | 2.03 |
| Price to Cash Ratio | 0.7 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 10.71M |
| Average Volume (1 week) | 44.53k |
| Average Volume (1 Month) | 49.03k |
| 52 Week Change | -72.19% |
| 52 Week High | 5.99 |
| 52 Week Low | 0.95 |
| Spread (Intraday) | 0.03 (2.33%) |
| Company Name | Marker Therapeutics Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.markertherapeutics.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
